Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

When it comes to comparing responses written by psychotherapists to those written by ChatGPT,the latter are generally rated higher, according to a study published February 12, 2025, in the open-access ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

ASCO Genitourinary Cancers Symposium approaches, several highly anticipated studies are set to shape the future of treatment ...

It's uncommon in women under the age of 45. This cancer is more common in Black women than in White women. Incidence rates have increased by more than1% per year since the mid-2000s. Over the past ...

Federal Reserve Chair Jerome Powell told lawmakers on Tuesday the argument for free trade still makes sense but added that it was not the role of the central bank to comment on tariff or trade policy ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

Radiation dose intensification improves pathologic complete response rates in locally advanced rectal cancer but also leads ...

Better access and capability scores were associated with integrated practice ownership and participation in accountable care ...

Researchers have used mathematical analysis tools to study the effect of classical music on a fetal heartbeat and identify patterns in heart rate variability. They recruited 36 pregnant women and ...

In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an ...

Marwan G. Fakih, MD, explains the implications of the findings from the phase 2 trial of balstilimab plus botensilimab for ...